title: An outbreak of cutaneous leishmaniasis among soldiers in Belém, Pará State, Brazil, caused by Leishmania (Viannia) lindenbergi n. sp. A new leishmanial parasite of man in the Amazon region.
abstract: Eight cases of cutaneous leishmaniasis are recorded among soldiers of the Brazilian Forest Infantry stationed in Belém, State of Pará, north of Brazil. The infections, all acquired during manoeuvres in nearby degraded primary forest, are attributed to a new member of the subgenus Viannia, Leishmania (V.) lindenbergi n. sp. A further infection by this parasite was encountered in a woman, who lived very close to the same piece of forest. The new parasite has been characterised and differentiated from other known species of the subgenus Viannia following the combined use of enzyme electrophoresis and monoclonal antibodies techniques. The eco-epidemiology of L. (V.) lindenbergi is discussed: by far the most abundant anthropophilic sandfly in the type locality was identified as Lutzomyia (Nyssomyia) antunesi (Coutinho), and this remains high on the list of possible vectors.
authors.affiliation: Departamento de Parasitologia, Instituto Evandro Chagas (FNS), Caixa Postal 1128, Belém, Pará, Brazil.
authors.forename: F T
authors.initials: FT
authors.lastname: Silveira
authors.forename: E A Y
authors.initials: EA
authors.lastname: Ishikawa
authors.forename: A A A
authors.initials: AA
authors.lastname: De Souza
authors.forename: R
authors.initials: R
authors.lastname: Lainson
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology; D000913:Antibodies, Protozoan / Q000276:immunology; D000953:Antigens, Protozoan / Q000276:immunology; D000981:Antiprotozoal Agents / Q000627:therapeutic use; D001938:Brazil / Q000453:epidemiology; D004196:Disease Outbreaks; D005260:Female; D006801:Humans; D007303:Insect Vectors / Q000469:parasitology; D007527:Isoenzymes / Q000032:analysis; D007891:Leishmania / Q000145:classification / Q000254:growth & development / Q000276:immunology / Q000302:isolation & purification* / Q000648:ultrastructure; D016773:Leishmaniasis, Cutaneous / Q000188:drug therapy / Q000453:epidemiology* / Q000469:parasitology; D008297:Male; D015767:Mefloquine / Q000627:therapeutic use; D008536:Meglumine / Q000627:therapeutic use; D000077485:Meglumine Antimoniate; D008889:Military Personnel; D009942:Organometallic Compounds / Q000627:therapeutic use; D015800:Protozoan Proteins / Q000032:analysis; D011576:Psychodidae / Q000469:parasitology; D014197:Trees
chemical_list: D000911:Antibodies, Monoclonal; D000913:Antibodies, Protozoan; D000953:Antigens, Protozoan; D000981:Antiprotozoal Agents; D007527:Isoenzymes; D009942:Organometallic Compounds; D015800:Protozoan Proteins; D008536:Meglumine; D000077485:Meglumine Antimoniate; D015767:Mefloquine